58.63
7.74 (15.21%)
| Previous Close | 50.89 |
| Volume | 4,412,988 |
| Price / Earnings (Forward) | 111.80 |
| Price / Sales | 9.85 |
| Price / Book | 6.12 |
| 52 Weeks Range |
| Profit Margin | -3.68% |
| Operating Margin (TTM) | -3.42% |
| Diluted EPS (TTM) | -0.160 |
| Quarterly Revenue Growth (YOY) | 17.40% |
| Total Debt/Equity (MRQ) | 67.39% |
| Current Ratio (MRQ) | 4.28 |
| Operating Cash Flow (TTM) | 3.62 M |
| Levered Free Cash Flow (TTM) | 2.84 M |
| Return on Assets (TTM) | -0.13% |
| Return on Equity (TTM) | -7.22% |
AIStockmoo Score
| Value 38% | 0.0 |
| From our AI Insight report's view of expected return against risk. info | NA |
| Relative Valuation info | NA |
| Implied Growth info | NA |
| Valuation History info | NA |
| Low debt. Weak profitability. Ample short-term liquidity. Positive cash flow. info | |
| Return on Capital info | NA |
| Timing 38% | 4.0 |
| From our AI technical analysis of the chart. info | NA |
| Uptrend over the past year. Trading near its 52-week high. info | |
| Price and its moving averages are lined up in an uptrend. Its main moving average is flat. Stretched well above its moving average. Volume is heavier on up days. info | |
| Candle Patterns info | NA |
| Above its medium-term trend line. info | |
| Sentiment 25% | 0.0 |
| No recent price targets, so based on how targets have been revised. info | |
| News Mood info | NA |
| Smart Money | NA |
| Insider Activity info | NA |
| Institutional Flow info | NA |
| Short Interest info | NA |
| Market and sector conditions are poor. | |
| Market environment cautious. info | |
| Sector lagging the market. | |
| Only one pillar has a clear reading, so the score is unchanged. | |
| Not in score | |
| Price is high against its 52-week average. Up over 5 years. info | |
| Trend up on all three terms. Short-term momentum rising. info | |
| No clear signal from support and resistance. info | |
| Final Score | 1.32 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | AxoGen, Inc. | Mixed | Bullish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| AXGN | - | - | - | 6.12 |
| UFPT | - | - | - | 4.88 |
| NNOX | - | - | - | 0.310 |
| QTI | - | - | - | 13.92 |
| ESTA | - | - | - | 128.59 |
| NMTC | - | - | - | 1.80 |
Select this tab to load the latest available analysis.
|
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 4.84% |
| % Held by Institutions | 86.20% |
No data within this time range.
No data within this time range.
Recent Signals candle patterns and EMA crosses
Technical Setup Medium
AI Technical Analysis
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |